Director/Sr Director, Long-Acting Injectable & Bio-Nano Interface Characterization

Role: Senior scientific leader in long-acting injectable (LAI) and bio-nano interface characterization within Lilly’s Drug Delivery group, focusing on polymer and lipid depot platforms to extend dosing and improve delivery of biologics, peptides, and nucleic acids. Responsibilities: define multi-year technical strategy, serve as a technical authority on depot systems and bio-nano interactions, lead cross-functional teams, foster external collaborations, and oversee preclinical studies for platform de-risking. Requirements: PhD in pharmaceutical sciences, chemical/biomedical engineering, or related field; 8+ years in industry with expertise in long-acting injectable/depot formulations, nanoparticle development, release-rate engineering, and physicochemical characterization; experience in regulated environments and AI/ML tools; proven leadership, mentorship, and scientific communication skills. HighValue: biologics, peptides, nucleic acids, depot and nanoparticle platforms, IND-enabling studies, bio-nano interface, PK/IVIVC modeling, advanced characterization techniques. WorkSetup: hands-on in-lab 25-50%, travel 10-15%.